Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo

  • Stephanie M. Cohen
  • , Ridhwi Mukerji
  • , Shuang Cai
  • , Ivan Damjanov
  • , M. Laird Forrest
  • , Mark S. Cohen

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science